Clinical trial
A Randomized, Parallel Group, Placebo-controlled, Double Blinded Clinical Trial to Evaluate the Efficacy and Safety of the Substance-based Medical Device (Sollievo Fisiolax) in the Treatment of Chronic Constipation.
NCT05192317 is registered in ClinicalTrials.gov with Aboca Spa Societa' Agricola as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Randomized, Parallel Group, Placebo-controlled, Double Blinded Clinical Trial to Evaluate the Efficacy and Safety of the Substance-based Medical Device (Sollievo Fisiolax) in the Treatment of Chronic Constipation.
- Lead sponsor
- Aboca Spa Societa' Agricola
- Phase
- Not applicable
- Overall status
- Unknown status
- Start date
- November 9, 2021
- Completion date
- September 30, 2023
- Enrollment
- 86 (estimated)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.
chronic constipation